Conmed (CNMD) Revenue (2010 - 2026)

Conmed's Revenue history runs 17 years deep, the most recent figure standing at $317.0 million for Q1 2026.

• Quarterly Revenue fell 1.31% year-over-year to $317.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 4.14% YoY) and the FY2025 annual result came in at $1.4 billion, up 5.18% from the prior year.
• Revenue was $317.0 million for Q1 2026 at Conmed, down from $373.2 million in the prior quarter.
• Across five years, Revenue topped out at $373.2 million in Q4 2025 and bottomed at $242.3 million in Q1 2022.
• A 5-year average of $311.1 million and a median of $317.0 million in 2026 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue fell 8.43% — and 2023, when it soared 30.37%.
• Conmed's Revenue stood at $250.9 million in 2022, then jumped by 30.37% to $327.0 million in 2023, then grew by 5.78% to $345.9 million in 2024, then gained by 7.88% to $373.2 million in 2025, then dropped by 15.05% to $317.0 million in 2026.
• Business Quant data shows CNMD's Revenue at $317.0 million in Q1 2026, $373.2 million in Q4 2025, and $337.9 million in Q3 2025.